Better living through chemistry: Addressing emerging antibiotic resistance

被引:9
作者
Coussens, Nathan P. [1 ]
Molinaro, Ashley L. [2 ]
Culbertson, Kayla J. [2 ]
Peryea, Tyler [1 ]
Zahornszky-Kohalmi, Gergely [1 ]
Hall, Matthew D. [1 ]
Daines, Dayle A. [2 ]
机构
[1] Natl Ctr Adv Translat Sci, Div Preclin Innovat, Rockville, MD 20850 USA
[2] Old Dominion Univ, Dept Biol Sci, Norfolk, VA 23529 USA
基金
美国国家卫生研究院;
关键词
Bacteria; drugs; mechanisms; pharmacology; resistance; small molecule inhibitors; SPECTRUM BETA-LACTAMASE; ESCHERICHIA-COLI; STAPHYLOCOCCUS-AUREUS; EFFLUX PUMPS; STREPTOCOCCUS-PNEUMONIAE; PSEUDOMONAS-AERUGINOSA; CARBAPENEM RESISTANCE; BACTERIAL-RESISTANCE; DRUG-COMBINATIONS; RISK;
D O I
10.1177/1535370218755659
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The increasing emergence of multidrug-resistant bacteria is recognized as a major threat to human health worldwide. While the use of small molecule antibiotics has enabled many modern medical advances, it has also facilitated the development of resistant organisms. This minireview provides an overview of current small molecule drugs approved by the US Food and Drug Administration (FDA) for use in humans, the unintended consequences of antibiotic use, and the mechanisms that underlie the development of drug resistance. Promising new approaches and strategies to counter antibiotic-resistant bacteria with small molecules are highlighted. However, continued public investment in this area is critical to maintain an edge in our evolutionary "arms race" against antibioticresistant microorganisms.
引用
收藏
页码:538 / 553
页数:16
相关论文
共 118 条
  • [1] An enzyme from bacteria able to destroy penicillin
    Abraham, EP
    Chain, E
    [J]. NATURE, 1940, 146 : 837 - 837
  • [2] Abraham EP, 1941, LANCET, V2, P177
  • [3] Auranofin efficacy against MDR Streptococcus pneumoniae and Staphylococcus aureus infections
    Aguinagalde, Leire
    Diez-Martinez, Roberto
    Yuste, Jose
    Royo, Inmaculada
    Gil, Carmen
    Lasa, Inigo
    Martin-Fontecha, Mar
    Marin-Ramos, Nagore Isabel
    Ardanuy, Carmen
    Linares, Josefina
    Garcia, Pedro
    Garcia, Ernesto
    Sanchez-Puelles, Jose M.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2015, 70 (09) : 2608 - 2617
  • [4] An Escherichia coli chromosomal ''addiction module'' regulated by 3',5'-bispyrophosphate: A model for programmed bacterial cell death
    Aizenman, E
    EngelbergKulka, H
    Glaser, G
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (12) : 6059 - 6063
  • [5] [Anonymous], 2016, NAM PERSPECTIVES, DOI DOI 10.31478/201606D
  • [6] [Anonymous], ANTIMICROB AGENTS CH
  • [7] [Anonymous], COLD SPRING HARB PER
  • [8] [Anonymous], ENV INT
  • [9] To the G20: incentivising antibacterial research and development
    Ardal, Christine
    Baraldi, Enrico
    Ciabuschi, Francesco
    Outterson, Kevin
    Rex, John H.
    Piddock, Laura J. V.
    Findlay, David
    [J]. LANCET INFECTIOUS DISEASES, 2017, 17 (08) : 799 - 801
  • [10] Underlying mechanisms of carbapenem resistance in extended-spectrum β-lactamase-producing Klebsiella pneumoniae and Escherichia coli isolates at a tertiary care centre in Lebanon: role of OXA-48 and NDM-1 carbapenemases
    Baroud, M.
    Dandache, I.
    Araj, G. F.
    Wakim, R.
    Kanj, S.
    Kanafani, Z.
    Khairallah, M.
    Sabra, A.
    Shehab, M.
    Dbaibo, G.
    Matar, G. M.
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2013, 41 (01) : 75 - 79